Customers of CarePath are notified by IBM of unauthorized data access.

Published Date: 09 Sep 2023

According to IBM, a "data incident" involving unauthorized access to personal data is being reported to Janssen CarePath customers, a Johnson and Johnson division.

Read Full News

Latest News

Medline Draws Another US FDA Warning in Two Months Over Quality Lapses

The U.S. FDA issued a warning letter to medical device maker Medline over violations of manufacturing quality standards, the ⁠second such action against the company in two...

Boehringer Ingelheim Launches AI Centre for Pharma Research in London

German drugmaker Boehringer Ingelheim is launching a centre for artificial intelligence and machine learning ⁠in London, it said on Monday, as it seeks to expand its AI...

How Much Do Long Wait Times Cost Canadian Patients?

Long wait times for surgery and medical treatment cost Canadians over $4.2 billion in lost wages and productivity in 2025.

Virtual Physiotherapy Shows Promise for Chronic Cough

A single 1-hour virtual group physiotherapy intervention for chronic cough achieves high uptake and reduces cough severity and frequency.

Germans Trust ‘Dr AI’ More Than Doctors Who Use It

Nearly half of Germans consult AI before seeing a physician, and some rate chatbot advice as equal to a medical second opinion.

Neurology Clinics are Adopted by Genetic Therapies.

There are new treatments for genetic neuromuscular diseases in the works, which will present challenges for neurologists as well as opportunities for patients.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Todays Updates

Hyponatremia Risk Varies Among Second-Gen Antipsychotics

Aripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Latest News

The U.S. FDA issued a warning letter to medical device maker Medline over violations of manufacturing quality standards, the ⁠second such action against the company in two...

German drugmaker Boehringer Ingelheim is launching a centre for artificial intelligence and machine learning ⁠in London, it said on Monday, as it seeks to expand its AI...

Long wait times for surgery and medical treatment cost Canadians over $4.2 billion in lost wages and productivity in 2025.

A single 1-hour virtual group physiotherapy intervention for chronic cough achieves high uptake and reduces cough severity and frequency.

Nearly half of Germans consult AI before seeing a physician, and some rate chatbot advice as equal to a medical second opinion.

There are new treatments for genetic neuromuscular diseases in the works, which will present challenges for neurologists as well as opportunities for patients.

News All Time

Hippocratic AI Raises Funds to Create Healthcare Models.

A startup developing artificial intelligence models for the healthcare sector, Hippocratic AI, has raised $50 million in a larger-than-normal seed funding round.

WHO Issues Warning Against Misinformation When Using AI in Healthcare.

On Tuesday, the World Health Organization warned against using AI in public healthcare because the data it uses to make decisions may be biased or misapplied.

US Jury Rules in Favor of Natera in Cancer-Detection Patent Case.

Monday, a federal jury in Delaware was persuaded to award genetic testing company Natera Inc. $19.3 million in damages from Invitae Corp.'s ArcherDX for infringing patents pertaining to cancer detection.

Changes in Hypertrophic Cardiomyopathy Risk Stratification?

Data show that compared to 24-hour monitoring, extended ECG monitoring detects a higher incidence of clinically relevant arrhythmias.

New Trials in Breast Cancer: Could Your Patient Benefit?

Perhaps one of your patients qualifies to participate in a clinical trial that is currently looking for breast cancer patients.

The Musk Animal Testing Panel Is Riddled With Possibilities.

A board overseeing animal research has been staffed by insiders from Elon Musk's brain-implant business who could profit financially as the company advances.

Drugmakers increase their research spending and look for deals.

As the larger players in the sector look for new sources of long-term revenue, drugmakers announced on Thursday that they are open to acquisitions and that their R&D spending has increased.

EU Law Reform Could Lead to a Shift in Investments: GSK.

The European Union's pharmaceutical industry is governed by new laws, which the British pharmaceutical company GSK warned on Wednesday run the risk of driving businesses to innovate and invest elsewhere.

Proposed Drug Law Reforms Published by the EU.

On Wednesday, Brussels released a long-awaited draft of its proposed overhaul of the laws governing the pharmaceutical industry in the European Union, setting off a dispute with drugmakers who threaten to invest and innovate elsewhere.

BioNTech and DualityBio will develop cancer drugs worth more than $1.5 billion

German company BioNTech said on Monday that it has signed an agreement with Chinese biotech company DualityBio to jointly develop and commercialize two cancer drug candidates.

Musk's brain transplant company seeks human collaboration

Elon Musk's neuroimplantation company Neuralink has reached one of the largest neurosurgical centers in the country capable of testing partners as it plans to test human devices if the regulator.

FDA moves to quickly approve gene therapy

The FDA is making important changes to gene therapy development, including encouraging the use of biomarkers that help recommend treatments for serious conditions, FDA officials said.

AI pab kwv yees ulcerative colitis remission/activity, relapse.

AI tools can distinguish between functional and histological clearance and predict the severity of ulcerative colitis biopsies, and can play a role in clinical trials and routine practice.

The fall of SVB casts a shadow over the beginnings of American biotechnology

The Silicon Valley banking meltdown will leave biotech start-ups with different funding options, investors and analysts said Monday.

SVB shock could have chilling effect on UK biotech sector

HSBC's bailout of the UK branch of the Silicon Valley bank has saved Britain's main biotech sector from collapse, but funding a sector the government sees as essential for the growth of the future economy could be affected, according to industry executives.

The risk of stent infection is low but can be reported

A review of stent coronary artery disease has led researchers to question whether these events are underreported.

Recommended News For You

Is Laughter Good for Blood Glucose Control?

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects

Glioblastoma treatment breakthrough shows promise

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

Recommended Articles For You

The Latest Advances in Glioblastoma Treatment and Prevention  

A Closer Look at MCV Modules: Features, Functions, and Benefits  

The importance of understanding normal serum osmolality 

Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

3.

Taking vitamin D daily decreased cancer mortality, according to a study.

4.

Study reveals increase in late-stage breast cancer diagnoses in US

5.

Prostate cancer Q&A: Improving detection and reducing overtreatment

1.

Virtual Survivorship Platforms in Cancer Care: Transforming Post-Treatment Support and Outcomes

2.

Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment

3.

Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025

4.

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide

5.

Women's Cancer Survivorship: Emerging Long-Term Health Priorities

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

3.

Expert Perspectives on Hematology

4.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

5.

Navigating the Complexities of Ph Negative ALL - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot